Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

HK$41.58As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2315Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR 11.90%
Div yield —
ROE 21.35%
Biotechnology
Beta (5Y) 0.15
PE TTM 42.07
TSR TTM 48.50%
Mkt cap HK$35.57B
ROIC 12.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$45
8.47%
(48.57%)
Hold 6|12|8|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.72
0.78
0.77
0.85
28.59%
31.55%
19.76%
25.60%
Revenue¥B
4.307
4.252
4.487
4.471
7.24%
1.76%
7.07%
1.00%
Peers (US$4.537B)
Cap (US$)
PE
4.882B
29.91x
4.719B
—
4.470B
9.667x
4.534B
—
Capital
TTM
5Y
10Y
Leveragex
1.702
0.296
0.278
EBIT/Intx
0.736
0.332
0.283
Own earn%
(45.89)
(222.90)
(198.18)
Sh yield%
45.93
34.99
34.78
Owners
Insiders/Inst%
11.08
29.52
Short interest%
4.01
SBC / revenue%
4.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
10–14
$1 testx
−1.7
Incr. ROIC%
6